Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.58101 | 24 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.56559 | 24 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.56698 | 24 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.52232 | 25 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.52285 | 25 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.18962 | 47 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.60154 | 24 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.54629 | 24 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.72511 | 33 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.55854 | 25 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.5971 | 26 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.54656 | 25 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.55227 | 24 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.52631 | 23 |